Posts by Sandra Ansanay-Alex
Moonlight AI AG Raises $3.3M Seed Round
Moonlight AI AG, a Swiss startup building image analysis software for clinical-grade diagnostics, has closed a $3.3 million USD Seed round. The investment was co-led by Lotus One Investment (Singapore), VP Venture Partners (Switzerland), and MEDIN Fund (Tunisia), with participation from N&V Capital (Liechtenstein) and existing investor QAI Ventures (Switzerland). Turning routine slide images into…
Read MoreSwiss Biotech on the Rise: Strong Momentum in 2025
Switzerland’s biotech sector continues to demonstrate remarkable resilience and growth, even in a complex global environment. According to the latest Swiss Biotech Report 2026, the industry reached new heights in 2025—both in terms of revenue and investment—further strengthening the country’s position as a global life sciences powerhouse. Record performance in a challenging context The numbers…
Read MoreMIE – Call For Projects
Apply before 17 May 2026 for the Medtech Innovation Event call for projects and get a chance to pitch in front of industry representatives and investors. Are you a startup active in Medtech and/or Healthtech field? Apply for our Pitching Session and get the chance to present your products and services in front of investors,…
Read MoreNestlé Vital
Apply before 8 May 2026 for the Nestlé Vital call for projects and pitch at Vivatech next June in Paris Aging the smart way is about adopting small lifestyle shifts, that overtime become healthy habits. Habits in the territories of nutrition, body and mind. Nestlé aims to help consumers adopt these small lifestyle shifts.The company…
Read MoreBayer – Co.Lab
Apply before 15 June 2026 for the Bayer Co.Lab programme. Get up to CHF 50,000 and personalised coaching If you’re an early-stage life science start-up company in Switzerland with that next great idea, then Bayer Co.Lab Connect Basel can offer you the opportunity you need to succeed. Bayer Co.Lab Connect Basel provides startups with a…
Read MoreSantExpo
SantExpo, one of France’s largest gathering dedicated to healthcare, is taking place from 19 to 21 May in Paris. SantExpo is the premier event for healthcare decision-makers and professionals: in 2025, it brought together 35,150 attendees, 695 exhibitors, and 530 speakers to discuss the sector’s strategic challenges. The theme for 2026 is “excellence in health”.…
Read MoreCHUV Acquires a Single-Incision Surgical Robot
Up to 400 patients per year could benefit from the “Da Vinci Single Port” system, developed by Intuitive Surgical, which is designed to minimize tissue damage—and thus speed up recovery time. The University Hospital of Lausanne (CHUV) announces the launch of a single-port surgical robot—a first in French-speaking Switzerland, according to the institution. The “Da…
Read MoreTwo Research Teams from HUG and UNIGE Awarded the 2026 Leenaards Scientific Prize
Two research groups from Hôpitaux Universitaires de Genève (HUG) and Université de Genève (UNIGE) have been awarded the 2026 Leenaards Foundation Scientific Prize, with total funding of nearly CHF 1.4 million. The award supports two biomedical research projects conducted in the Lake Geneva region, focusing respectively on hepatitis E and an innovative, non-invasive approach to…
Read MoreMedtronic Reaches 10 Million Implantable Devices Produced in Switzerland
In Switzerland, precision and innovation are more than values—they are an industrial signature. Few companies embody that better than Medtronic, which is celebrating a dual milestone: 50 years of presence in the country and the production of its 10 millionth implantable device at its Tolochenaz (Canton of Vaud) site. A Swiss industrial success story Medtronics…
Read MoreMindMaze Therapeutics Narrows Losses and Prepares for Commercial Takeoff in 2026
MindMaze Therapeutics’ 2025 Annual Report tells a story of transition—one where financial discipline begins to align with long-term commercial ambition. The Swiss-based neurotechnology company gears up for a broader market launch in 2026. Mindmaze reported CHF 0.6 million in revenue for 2025, alongside operating expenses of CHF 11.2 million and a net loss of CHF…
Read More